Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2024 08:00 ET | Source: Allyx Therapeutics Inc.

Allyx Therapeutics Announces First Parkinson’s Disease Patient Treated with ALX-001

Allyx Therapeutics first patient first patient has been dosed with its lead compound, ALX-001, in new Parkinson's Disease clinical study
March 11, 2024 08:05 ET | Source: Allyx Therapeutics Inc.

Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients

Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients